According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...

The company raised $200 million after early findings hinted its therapy could be more potent than others like it, including ...

PHC Corporation and CCRM have signed a Master Collaboration Agreement to collaborate on developing primary T-cell expansion ...

The alliance will focus on optimising and enhancing the production process of TCR therapies targeting ... which is instrumental in cell and gene therapy research and development.

Upstream Processing Segment to Dominate the Asia-Pacific Cell and Gene Therapy Manufacturing QC Market (by Process) Based on process, the upstream processing segment accounted for the largest ...

Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.

Beam Therapeutics Inc. (NASDAQ:BEAM)’s newly developed automated CD34+ cell process for BEAM-101 manufacturing is expected to revolutionize gene therapy. By increasing process capacity threefold ...

The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...